Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Targets and Mechanisms group within Discovery Biology leverages expertise in cancer biology and deep mechanistic understanding of cancer-relevant pathways to identify and characterize high-priority oncology targets for our tri-complex inhibitor (TCI) platform. We are looking for an experienced drug hunter to lead the Target Biology team, provide hands-on scientific and people leadership, and work cross-functionally to identify and rapidly assess promising new targets, determine hit identification strategy, and advance screening hits through the early stages of hit-to-lead discovery. The ideal candidate will be a strategic thinker and an accomplished scientist with experience identifying and vetting targets for oncology programs, familiarity with different targeting modalities, including molecular glues, and hands-on hit to lead experience.
In this role you will:
-
Lead a team of scientists focused on target identification, prioritization, and biological validation.
-
Work cross-functionally with partners in Medicinal Chemistry, Structural Biology, Discovery Biology, Translational Research, and Cancer Immunology to prioritize oncology targets, implement hit discovery plans, and drive progression from hit identification through lead generation.
-
Collaborate with the Translational Research function to apply learnings from clinical and preclinical studies to inform new target identification and prioritization.
-
Spearhead innovative approaches and technologies for target discovery and hit identification, specifically in the context of hard-to-drug oncology targets.
-
Provide scientific leadership to the team, including technical guidance, coaching, and mentoring.
-
Foster a culture of curiosity, scientific rigor, and excellence, driven by RevMed’s core values and commitment to improving patients’ lives.
-
Implement data-driven decision-making processes to prioritize targets and allocate resources effectively.
Required Skills, Experience and Education:
We are looking for a driven team leader and an excellent team player to guide the Target Biology team and support overall Discovery Biology efforts.
-
PhD in chemical biology, cell-biology, biochemistry, or a related scientific discipline.
-
Minimum of 10 years of industry experience, ideally in early-stage drug discovery.
-
Experience as a team leader in an industry setting with demonstrated ability to build strong cross-functional relationships and effectively drive early discovery programs.
-
Proven problem solver with strong scientific background and expertise in experimental design and data interpretation.
-
Excellent communication and decision-making skills.
Preferred Skills:
-
Knowledge of molecular glue discovery, cellular models, phenotypic screening, and target identification by chemical labeling.
-
Familiarity with multi-omics data, genetic screens (e.g., synthetic lethality) and their application in early discovery.
-
Experience applying advanced analytical techniques (e.g. AI and ML) to generate hypotheses from large, multidimensional data sets.
-
Project team leadership experience in early-stage discovery programs.
-
Experience working with different modalities, such as small molecules, biologics, and molecular glues.
#LI-Hybrid #LI-LN1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
